Cargando…
In Silico Study: Combination of α-Mangostin and Chitosan Conjugated with Trastuzumab against Human Epidermal Growth Factor Receptor 2
Breast cancer is a type of cancer with the highest prevalence worldwide. Almost 10–30% of breast cancer cases are diagnosed as positive for HER2 (human epidermal growth factor receptor 2). The currently available treatment methods still exhibit many shortcomings such as a high incidence of side effe...
Autores principales: | Megantara, Sandra, Wathoni, Nasrul, Mohammed, Ahmed Fouad Abdelwahab, Suhandi, Cecep, Ishmatullah, Maryam H., Putri, Melisa F. F. D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268814/ https://www.ncbi.nlm.nih.gov/pubmed/35808792 http://dx.doi.org/10.3390/polym14132747 |
Ejemplares similares
-
Propolis-Based Nanostructured Lipid Carriers for α-Mangostin Delivery: Formulation, Characterization, and In Vitro Antioxidant Activity Evaluation
por: Suhandi, Cecep, et al.
Publicado: (2023) -
Cytotoxicity Enhancement of α-Mangostin with Folate-Conjugated Chitosan Nanoparticles in MCF-7 Breast Cancer Cells
por: Herdiana, Yedi, et al.
Publicado: (2023) -
Nanoformulations of α-Mangostin for Cancer Drug Delivery System
por: Meylina, Lisna, et al.
Publicado: (2021) -
Alginate/Chitosan-Based Hydrogel Film Containing α-Mangostin for Recurrent Aphthous Stomatitis Therapy in Rats
por: Milanda, Tiana, et al.
Publicado: (2022) -
Synthesis of nano-α mangostin based on chitosan and Eudragit S 100
por: Herdiana, Yedi, et al.
Publicado: (2020)